|
Real-time Estimate
Cboe Europe
06:55:44 2026-10-19 am EDT
|
5-day change | 1st Jan Change | ||
| 12,348.00 GBX | -0.79% |
|
+2.63% | -10.50% |
| 05:00am | AstraZeneca to unveil major oncology advances at the 2026 ESMO Congress |  |
| Oct. 16 | FTSE forges ahead but banks stutter on tax threat | AN |
| Market Cap | 258B 229B 212B 193B 364B 24,441B 370B 2,550B 1T 12,754B 966B 946B 40,659B | P/E 2026 * |
21.7x | P/E 2027 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 278B 247B 229B 208B 393B 26,349B 399B 2,749B 1,078B 13,750B 1,042B 1,020B 43,833B | EV / Sales 2026 * |
4.38x | EV / Sales 2027 * | 4.01x |
| Free-Float |
96.62% | Yield 2026 * |
2.01% | Yield 2027 * | 2.14% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
CBOE
| AZN | Real-time | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript: AstraZeneca PLC
| 1 day | -0.64% | ||
| 1 week | +2.74% | ||
| Current month | +0.62% | ||
| 1 month | -1.62% | ||
| 3 months | -0.19% | ||
| 6 months | -17.36% | ||
| Current year | -10.40% |
| 1 week | 11,816 |  | 12,806 |
| 1 month | 11,716 | | 12,806 |
| Current year | 10,524 | | 15,732 |
| 1 year | 10,524 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,090.32 | | 15,732 |
| 10 years | 3,996 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Pam Cheng
COO | Chief Operating Officer | 55 | 2015-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/6/26 | Free | See remarks | 2 | 0.0000% | - | |
| 9/14/26 | Free | Chief Financial Officer | 73 | 0.0000% | ||
| 9/14/26 | Buy | Chairman | 2,500 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | +2.74% | -1.66% | +17.81% | 258B | |
| +0.43% | +6.59% | +56.57% | +107.01% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +67.33% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.20% | 504B | |
| +0.07% | +5.28% | +34.83% | +58.94% | 367B | |
| +0.52% | +0.24% | +72.13% | +43.10% | 360B | |
| +0.06% | +4.02% | +19.82% | +47.23% | 288B | |
| -0.35% | +4.25% | +44.74% | +52.51% | 234B | |
| -0.75% | +3.32% | +27.18% | +96.05% | 194B | |
| -0.76% | +0.51% | -28.38% | -62.34% | 173B | |
| Average | -0.14% | +3.15% | +28.18% | +51.88% | 411.37B | |
| Weighted average by Cap. | +0.03% | +3.44% | +36.56% | +68.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.4B 56.36B 52.24B 47.53B 89.68B 6,017B 91.12B 628B 246B 3,140B 238B 233B 10,010B | 67.37B 59.89B 55.51B 50.5B 95.3B 6,394B 96.82B 667B 262B 3,337B 253B 247B 10,637B |
| Net income | 11.79B 10.48B 9.71B 8.84B 16.68B 1,119B 16.95B 117B 45.79B 584B 44.25B 43.31B 1,862B | 13.65B 12.14B 11.25B 10.23B 19.31B 1,296B 19.62B 135B 53.01B 676B 51.23B 50.14B 2,155B |
| Net Debt | 20.11B 17.87B 16.56B 15.07B 28.44B 1,908B 28.9B 199B 78.07B 996B 75.45B 73.85B 3,174B | 12.46B 11.08B 10.27B 9.34B 17.62B 1,183B 17.91B 123B 48.38B 617B 46.76B 45.77B 1,967B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | GBX 12,342.00 | -0.84% | 202,349 |
| 26-10-16 | GBX 12,446.00 | -1.98% | 2,901,078 |
| 26-10-15 | GBX 12,698.00 | +3.24% | 5,442,068 |
| 26-10-14 | GBX 12,300.00 | +3.40% | 2,182,103 |
| 26-10-13 | GBX 11,896.00 | -1.08% | 2,152,485 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
